Alzheimer's disease

IGC starts clinical trial of drug candidate to treat agitation in dementia
Clinical Trials Arena
Fri, 12/2/22 - 11:00 am
IGC
clinical trials
IGC-AD1
Alzheimer's agitation
Alzheimer's disease
Lilly’s Donanemab Shines vs. Aduhelm in First Active Comparator Study
BioSpace
Thu, 12/1/22 - 07:10 pm
Eli Lilly
donanemab
clinical trials
Aduhelm
Biogen
Alzheimer's disease
CTAD 2022 – lecanemab data hold up, with a big but
EP Vantage
Thu, 12/1/22 - 07:01 pm
Biogen
Eisai
Alzheimer's disease
CTAD
lecanemab
clinical trials
J&J unit, happy with AC Immune Alzheimer's work, moves 1 of 2 shots to next step
Fierce Biotech
Thu, 12/1/22 - 10:33 am
JNJ
AC Immune
Alzheimer's disease
Janssen
vaccines
ACI-35.030
CTAD 2022 – gantenerumab’s shortcomings keep amyloid hypothesis alive
EP Vantage
Thu, 12/1/22 - 10:28 am
Roche
clinical trials
CTAD
Alzheimer's disease
gantenerumab
What to make of Eisai and Biogen’s latest Alzheimer’s drug data
BioPharma Dive
Tue, 11/29/22 - 10:58 pm
Biogen
Eisai
Alzheimer's disease
lecanemab
Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal
Fierce Biotech
Mon, 11/28/22 - 07:51 pm
Biogen
Eisai
clinical trials
patient death
lecanemab
Alzheimer's disease
Axsome Headed to FDA after Phase III Alzheimer's Agitation Win
BioSpace
Mon, 11/28/22 - 10:23 am
Axsome Therapeutics
clinical trials
Alzheimer's disease
Alzheimer's agitation
AXS-05
Roche Failure Leaves Industry Reassessing Alzheimer's Space
BioSpace
Wed, 11/16/22 - 10:45 am
Roche
Alzheimer's disease
gantenerumab
Biogen
Cassava Sciences
Eli Lilly
AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit
Fierce Pharma
Tue, 11/15/22 - 06:37 pm
legal
AbbVie
Namenda
Alzheimer's disease
pay-for-delay
Allergan
Trial failures end latest hope for Roche’s Alzheimer’s drug
BioPharma Dive
Mon, 11/14/22 - 10:57 am
Roche
Alzheimer's disease
gantenerumab
clinical trials
Cassava Files Defamation Suit against Short Sellers Linked to Data Manipulation Allegations - Updated
BioSpace
Fri, 11/4/22 - 10:16 am
Cassava Biosciences
legal
data manipulation
short sellers
simufilam
Alzheimer's disease
Why Denali Therapeutics' Stock Rose 6.6% on Wednesday
Motley Fool
Wed, 11/2/22 - 10:51 pm
Denali Therapeutics
clinical trials
Alzheimer's disease
TAK-594
Lilly powers through final stretch in critical Alzheimer's race
Fierce Biotech
Tue, 11/1/22 - 07:02 pm
Eli Lilly
Alzheimer's disease
donanemab
lecanemab
Eisai
Eisai's Alzheimer's hopeful lecanemab may have contributed to patient death: report
Fierce Biotech
Mon, 10/31/22 - 10:30 am
Eisai
patient death
lecanemab
Alzheimer's disease
clinical trials
Biogen's Q3 revenue declines 10% as focus shifts to new Alzheimer's and ALS drug candidates
Endpoints
Tue, 10/25/22 - 11:05 am
Biogen
earnings
Alzheimer's disease
ALS
tofersen
lecanemab
Where Will Biogen Be in 5 Years?
Motley Fool
Thu, 10/20/22 - 10:39 am
Biogen
Aduhelm
lecanemab
Alzheimer's disease
M&A
Roche CEO Cautious on Alzheimer’s Trial Despite Eisai’s Success
Bloomberg
Wed, 10/19/22 - 10:35 am
Roche
Pharma CEOs
Severin Schwan
Alzheimer's disease
Eisai
gantenerumab
lecanemab
4 Biotech Stocks With Huge Incoming Catalysts
Motley Fool
Wed, 10/12/22 - 11:03 am
FDA
Biogen
Eisai
Alzheimer's disease
Gilead Sciences
HIV
Mirati Therapeutics
lung cancer
lecanemab
lenacapavir
adagrasib
TauRx’s HMTM could be the first anti-tau disease-modifying drug for Alzheimer’s
Clinical Trials Arena
Tue, 10/11/22 - 04:17 pm
Alzheimer's disease
TauRx
clinical trials
HMTM

Pages